HSA
Hussman Strategic Advisors Portfolio holdings
AUM
$438M
This Quarter Return
+4.73%
1 Year Return
+4.51%
3 Year Return
+35.81%
5 Year Return
+93.33%
10 Year Return
+242.61%
AUM
$438M
AUM Growth
+$438M
(+6.1%)
Cap. Flow
+$12.9M
Cap. Flow
% of AUM
2.95%
Top 10 Holdings %
Top 10 Hldgs %
21.07%
Holding
312
New
80
Increased
50
Reduced
26
Closed
102
Top Buys
| 1 |
Agnico Eagle Mines
AEM
|
$8.49M |
| 2 |
InterDigital
IDCC
|
$4.71M |
| 3 |
Cognizant
CTSH
|
$4.1M |
| 4 |
Globe Life
GL
|
$3.92M |
| 5 |
EPAM Systems
EPAM
|
$3.71M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$4.92M |
| 2 |
AngloGold Ashanti
AU
|
$4.65M |
| 3 |
Globus Medical
GMED
|
$3.84M |
| 4 |
Concentrix
CNXC
|
$3.51M |
| 5 |
Bunge Global
BG
|
$3.21M |
Sector Composition
| 1 | Healthcare | 22.59% |
| 2 | Technology | 17.67% |
| 3 | Materials | 16.79% |
| 4 | Financials | 11.81% |
| 5 | Consumer Staples | 11.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
EPAM Systems
EPAM
$9.62B
| $3.71M | 0.85% |
+21,000
| New | +$3.71M |
|
27
Genpact
G
$7.8B
| $3.7M | 0.84% |
+84,000
| New | +$3.7M |
|
28
Novo Nordisk
NVO
$252B
| $3.62M | 0.83% |
52,500
-10,500
| -17% | -$725K |
|
29
Alkermes
ALKS
$5.11B
| $3.6M | 0.82% |
+126,000
| New | +$3.6M |
|
30
Dole
DOLE
$1.39B
| $3.53M | 0.81% |
252,000
+105,000
| +71% | +$1.47M |
|
31
Norwegian Cruise Line
NCLH
$11.5B
| $3.41M | 0.78% |
+168,000
| New | +$3.41M |
|
32
Alamos Gold
AGI
$13.6B
| $3.39M | 0.77% |
127,500
+117,300
| +1,150% | +$3.12M |
|
33
PepsiCo
PEP
$203B
| $3.33M | 0.76% |
25,200
| – | – |
|
34
Harmony Biosciences
HRMY
$2.12B
| $3.32M | 0.76% |
105,000
+21,000
| +25% | +$664K |
|
35
Western Alliance Bancorporation
WAL
$9.84B
| $3.28M | 0.75% |
42,000
+21,000
| +100% | +$1.64M |
|
36
DocuSign
DOCU
$15.1B
| $3.27M | 0.75% |
+42,000
| New | +$3.27M |
|
37
General Mills
GIS
$26.2B
| $3.26M | 0.75% |
63,000
| – | – |
|
38
M&T Bank
MTB
$31.1B
| $3.26M | 0.74% |
16,800
+2,100
| +14% | +$407K |
|
39
Doximity
DOCS
$12.6B
| $3.22M | 0.74% |
+52,500
| New | +$3.22M |
|
40
Catalyst Pharmaceutical
CPRX
$2.51B
| $3.19M | 0.73% |
147,000
+63,000
| +75% | +$1.37M |
|
41
Kinross Gold
KGC
$26.6B
| $3.19M | 0.73% |
204,000
-102,000
| -33% | -$1.59M |
|
42
Appian
APPN
$2.26B
| $3.14M | 0.72% |
+105,000
| New | +$3.14M |
|
43
Astrana Health
ASTH
$1.41B
| $3.13M | 0.72% |
126,000
+42,000
| +50% | +$1.04M |
|
44
Corcept Therapeutics
CORT
$7.59B
| $3.08M | 0.7% |
42,000
| – | – |
|
45
PTC Therapeutics
PTCT
$4.37B
| $3.08M | 0.7% |
63,000
+42,000
| +200% | +$2.05M |
|
46
Cogent Communications
CCOI
$1.77B
| $3.04M | 0.69% |
63,000
+42,000
| +200% | +$2.02M |
|
47
Aurinia Pharmaceuticals
AUPH
$1.56B
| $3.02M | 0.69% |
357,000
+147,000
| +70% | +$1.25M |
|
48
Pediatrix Medical
MD
$1.48B
| $3.01M | 0.69% |
210,000
+126,000
| +150% | +$1.81M |
|
49
Bread Financial
BFH
$3.04B
| $3M | 0.69% |
52,500
+21,000
| +67% | +$1.2M |
|
50
lululemon athletica
LULU
$24.1B
| $2.99M | 0.68% |
+12,600
| New | +$2.99M |
|